Research location
Endwell
New York, United States
Advertisement
Research activity in Endwell
New York, United StatesCureCurrent currently publishes aggregate city-level research activity for this location: 42 trials and 42 site observations.
The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.
Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.
Trials with sites in Endwell
42 linked trials · page 1 of 1A Comparison of PT027 vs PT007 Used as Needed in Participants With AsthmaNCT05505734 · 2022-09-02 · 1 site observation
COMPLETED
Efficacy and Safety of GMRx2 Compared to Dual Combinations for the Treatment of HypertensionNCT04518293 · 2021-07-09 · 1 site observation
COMPLETED
A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITYNCT04617275 · 2021-01-06 · 1 site observation
COMPLETED
Research Study to Look at How Well Semaglutide is at Lowering Weight When Taken Together With an Intensive Lifestyle ProgramNCT03611582 · 2018-08-01 · 1 site observation
COMPLETED
Naltrexone/Bupropion Cardiovascular Outcomes StudyNCT02638129 · 2016-01-01 · 1 site observation
TERMINATED
A Dose Range Finding Study to Evaluate the Effect of Bexagliflozin Tablets in Subjects With Type 2 Diabetes MellitusNCT02390050 · 2015-05-12 · 1 site observation
COMPLETED
Evaluation of ETC-1002 in Participants With Hypercholesterolemia and HypertensionNCT02178098 · 2014-06-16 · 1 site observation
COMPLETED
A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk FactorsNCT02019264 · 2014-01-24 · 1 site observation
COMPLETED
A Study to Evaluate ITCA 650 Compared to Sitagliptin as add-on Therapy for the Treatment of Type 2 DiabetesNCT01455870 · 2013-05-01 · 1 site observation
COMPLETED
A Study to Evaluate ITCA 650 for the Treatment of Type 2 DiabetesNCT01455857 · 2013-03-01 · 1 site observation
COMPLETED
Efficacy and Safety of Exenatide Once Weekly Suspension in Subjects With Type 2 DiabetesNCT01652716 · 2013-01-01 · 1 site observation
COMPLETED
Immunogenicity and Safety Study of GlaxoSmithKline (GSK) Biologicals' Engerix™-B in Adults With or Without Type 2 Diabetes MellitusNCT01627340 · 2012-07-24 · 1 site observation
COMPLETED
Cardiovascular Outcomes Study of Naltrexone SR/Bupropion SR in Overweight and Obese Subjects With Cardiovascular Risk Factors (The Light Study)NCT01601704 · 2012-06-01 · 1 site observation
TERMINATED
SAS115359: A 6-month Study to Assess the Safety and Benefit of Inhaled Fluticasone Propionate/Salmeterol Combination Compared With Inhaled Fluticasone Propionate in the Treatment of Adolescents and Adults (12 Years of Age and Older) With Asthma.NCT01475721 · 2011-11-18 · 1 site observation
COMPLETED
Efficacy and Safety of Empagliflozin (BI 10773) / Linagliptin (BI 1356) Fixed Dose Combination in Treatment naïve and Metformin Treated Type 2 Diabetes PatientsNCT01422876 · 2011-08-01 · 1 site observation
COMPLETED
Effect of Liraglutide on Body Weight in Overweight or Obese Subjects With Type 2 Diabetes: SCALE™ - DiabetesNCT01272232 · 2011-06-01 · 1 site observation
COMPLETED
Efficacy and Safety of Empagliflozin (BI 10773) in Patients With Type 2 Diabetes and Renal ImpairmentNCT01164501 · 2010-07-01 · 1 site observation
COMPLETED
Does Saxagliptin Reduce the Risk of Cardiovascular Events When Used Alone or Added to Other Diabetes MedicationsNCT01107886 · 2010-05-01 · 1 site observation
COMPLETED
Comparison of Tiotropium in the HandiHaler Versus the Respimat in Chronic Obstructive Pulmonary DiseaseNCT01126437 · 2010-05-01 · 1 site observation
COMPLETED
1-year Study to Assess the Efficacy, Safety, and Tolerability of Glycopyrronium Bromide (NVA237) in Chronic Obstructive Pulmonary Disease (COPD)NCT00929110 · 2009-06-01 · 1 site observation
COMPLETED
A 12 Week Study in Patients With Type 2 Diabetes Mellitus (T2DM)NCT00901979 · 2009-04-01 · 1 site observation
COMPLETED
Efficacy and Safety of Azilsartan Medoxomil Combined With Chlorthalidone in Participants With Moderate to Severe HypertensionNCT00847626 · 2009-01-01 · 1 site observation
COMPLETED
Efficacy and Long-Term Safety of Vildagliptin as Monotherapy in Patients With Type 2 DiabetesNCT00821977 · 2008-11-01 · 1 site observation
COMPLETED
Comparison of Liraglutide Versus Placebo in Weight Loss Maintenance in Obese Subjects: SCALE - MaintenanceNCT00781937 · 2008-10-30 · 1 site observation
COMPLETED
Open-Label Extension (OLE) Study for Safety and Efficacy of Velneperit (S-2367) in Obese SubjectsNCT00788528 · 2008-08-01 · 1 site observation
COMPLETED
Efficacy and Safety of BI 1356 in Combination With Metformin in Patients With Type 2 DiabetesNCT00622284 · 2008-02-01 · 1 site observation
COMPLETED
Phase IIb One Year Efficacy and Safety Study of S-2367 in Obese Subjects With Initial 6-Week Low Calorie DietNCT00748605 · 2007-06-01 · 1 site observation
COMPLETED
Prospective Randomized Evaluation Of Celecoxib Integrated Safety Vs Ibuprofen Or NaproxenNCT00346216 · 2006-10-04 · 1 site observation
COMPLETED
Clinical Benefits of a Blood Glucose Monitoring System in Patients With Type 2 DiabetesNCT00401622 · 2006-10-01 · 1 site observation
COMPLETED
A Long-Term Study To Examine The Effects Of CP-945,598 On Weight Loss And SafetyNCT00375401 · 2006-10-01 · 1 site observation
TERMINATED
Efficacy and Safety of 3 Doses of BI1356 (Linagliptin) in Type 2 Diabetes PatientsNCT00328172 · 2006-05-01 · 1 site observation
COMPLETED
A Long-term Safety Study of Infliximab in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD).NCT00380796 · 2006-04-01 · 1 site observation
COMPLETED
COREG MR Versus TOPROL-XL On The Lipid Profile Of Normolipidemic Or Mildly Dyslipidemic Patients With HypertensionNCT00273052 · 2006-01-05 · 1 site observation
COMPLETED
A Study to Evaluate Combining Metformin With Muraglitazar or Pioglitazone in Type 2 DiabeticsNCT00240370 · 2003-10-01 · 1 site observation
COMPLETED
A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic ControlNCT00246987 · 2003-06-01 · 1 site observation
COMPLETED
"REDUCE" - A Clinical Research Study To Reduce The Incidence Of Prostate Cancer In Men Who Are At Increased RiskNCT00056407 · 2003-03-01 · 1 site observation
COMPLETED
To Evaluate the Long-term Safety of (R,R)-Formoterol in Subjects With COPDNCT00064415 · 2002-06-01 · 1 site observation
COMPLETED
A Pivotal Study of the Safety and Effectiveness of Arformoterol in Subjects With Chronic Obstructive Pulmonary Disease (COPD)NCT00685841 · 2002-02-01 · 1 site observation
COMPLETED
Study to Compare Pioglitazone and Rosiglitazone in Subjects With Type 2 Diabetes Mellitus and DyslipidemiaNCT00331487 · 2000-09-01 · 1 site observation
COMPLETED
Rosiglitazone on Microalbuminuria in Type 2 DiabeticsNCT00500955 · 2000-04-01 · 1 site observation
COMPLETED
Diabetes Study With Rosiglitazone Monotherapy Versus Metformin Or Glyburide/GlibenclamideNCT00279045 · 2000-01-03 · 1 site observation
COMPLETED
An Evaluation of an Oral Antidiabetic Agent for the Treatment of Type 2 DiabetesNCT00065312 · 1 site observation
COMPLETED
Advertisement
Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.